Position in AXSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,850,458
-$541,942 QoQ
Shares Held
34,614
-1.1% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
3.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Occam Crest Management LP holds $48,684,337 across 6 Biotechnology names. AXSM ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
577,000 | $19,167,940 | |
| 2 | PGEN |
Precigen, Inc.
|
4,269,051 | $16,521,227 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
34,614 | $5,850,458 | |
| 4 | NVCT |
Nuvectis Pharma, Inc.
|
407,147 | $3,147,246 | |
| 5 | IMRX |
Immuneering Corp
|
545,098 | $2,872,666 | |
| 6 | GHRS |
GH Research PLC
|
80,000 | $1,124,800 |
All Filings in AXSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,850,458 | 34,614 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,392,400 | 35,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,007,850 | 33,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||